Ten startups from Switzerland, Hungary and the UK made it to the finals of the pitch competition and Biospectal won the Health Tech track. Each company was allowed to present their work in a 100 seconds pitch, without slides. Biospectal was selected as the winner by the audience! Great achievement, thank you to all who
Innosuisse, the Swiss Innovation Agency, has featured Biospectal as a success story in fostering innovation through Swiss technology. The video profile highlights the unique opportunity Biospectal is pursuing in partnership with CSEM, the Swiss Center for Electronics and Microtechnology, to use software-only, cuffless blood pressure monitoring and management in smartphones to scale hypertension management globally.
Innosuisse, a key supporter of Biospectal’s research and development efforts, recently created a feature video to highlight the innovation we are pursuing in algorithm development to enable optical recording of blood pressure through the fingertip with a smartphone camera. We are grateful for their support and would not be where we are without it! The
We’re at it again! Come visit us in Lausanne, Switzerland on 16 May where Biospectal will present as one of three top innovators by Swiss Healthcare Startups. We’ll present to a select group at SHS Healthcare Madness with Antoine Hubert (Swiss Medical Network) and Nicolas Durand (Abionic) in attendance. For details, see: https://swisshealthcarestartups.com/en/events/shs-healthcare-madness
Biospectal joined a panel hosted by the Swiss Center for Electronics and Microtechnology (CSEM) on February 20th in Cambridge, Massachusetts to dialogue about Swiss and American perspectives on Digital Health Innovation. CSEM opened the evening by sharing their most recent innovations in health related technology, including a focus on health sensors and non-invasive approaches to
We are honored to have Biospectal’s cuffless optical blood pressure solution recognized by being awarded MassChallenge Switzerland’s 2018 Gold prize from a field of 1000 applicants and many talented cohort participants. A shout out to our technology research partner, CSEM for their brilliance and support. Professor Patrick Schoettker, co-founder and chief medical advisor of Biospectal,